IRIS Institutional Research Information System - OPENBS Open Archive UniBS

TRIGGIANI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.225
EU - Europa 1.759
AS - Asia 475
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
AF - Africa 3
Totale 6.483
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.216
PL - Polonia 451
CN - Cina 373
UA - Ucraina 362
IT - Italia 307
DE - Germania 246
FI - Finlandia 96
IE - Irlanda 91
GB - Regno Unito 78
FR - Francia 48
VN - Vietnam 46
BE - Belgio 26
IN - India 20
RU - Federazione Russa 18
SE - Svezia 15
TR - Turchia 15
CA - Canada 9
BR - Brasile 7
EU - Europa 6
GR - Grecia 6
AU - Australia 5
ID - Indonesia 3
JP - Giappone 3
MA - Marocco 3
NL - Olanda 3
BD - Bangladesh 2
HK - Hong Kong 2
IR - Iran 2
KR - Corea 2
SA - Arabia Saudita 2
SG - Singapore 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
AR - Argentina 1
AT - Austria 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
EE - Estonia 1
ES - Italia 1
HU - Ungheria 1
IS - Islanda 1
KW - Kuwait 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SI - Slovenia 1
TH - Thailandia 1
Totale 6.483
Salva come PNG Salva come JPEG
Città #
Fairfield 695
Warsaw 451
Woodbridge 422
Houston 329
Chandler 312
Ashburn 287
Seattle 286
Jacksonville 276
Cambridge 272
Wilmington 238
Ann Arbor 189
Princeton 163
Dearborn 143
Dublin 89
Helsinki 80
Brescia 79
Nanjing 74
Beijing 71
Dong Ket 46
San Diego 36
Washington 31
Des Moines 30
Brussels 26
Nanchang 26
Milan 25
Shenyang 25
Changsha 21
Jinan 21
Hebei 19
London 18
Kunming 16
Jiaxing 13
Lancaster 11
Ningbo 11
Hanover 10
Kocaeli 10
Redwood City 10
Zhengzhou 10
San Francisco 9
Hangzhou 8
Iseo 8
Tianjin 8
Haikou 7
Taizhou 7
Toronto 7
Athens 6
Ceto 6
Chiswick 6
Lumezzane 6
Nürnberg 6
Hefei 5
New Bedfont 5
Orange 5
Phoenix 5
Rome 5
Chicago 4
Chongqing 4
Cremona 4
Falls Church 4
San Mateo 4
Verona 4
Boardman 3
Changchun 3
Florence 3
Leawood 3
Monza 3
Rio De Janeiro 3
Solbiate Olona 3
Sydney 3
Ardabil 2
Augusta 2
Bologna 2
Bratislava 2
Böblingen 2
Casablanca 2
Como 2
Dallas 2
Dhaka 2
Grassobbio 2
Guangzhou 2
Gunzenhausen 2
Hamamatsu 2
Islington 2
Marcheno 2
New York 2
Norwalk 2
Riyadh 2
Rozzano 2
Shanghai 2
Siena 2
Singapore 2
Torino 2
Vignate 2
Wauwatosa 2
Arezzo 1
Bangkok 1
Bari 1
Bastia umbra 1
Bordighera 1
Cambados 1
Totale 5.084
Salva come PNG Salva come JPEG
Nome #
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study 194
Overexpression of sialidase NEU3 increases the cellular radioresistance potential of U87MG glioblastoma cells 185
Exploring All Avenues for Radiotherapy in Oligorecurrent Prostate Cancer Disease Limited to Lymph Nodes: A Systematic Review of the Role of Stereotactic Body Radiotherapy 171
Light and shadows of a new technique: Isphoton total-skin irradiation using helical IMRT feasible, less complex and as toxic as the electrons one? 166
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 152
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 146
Pros-IT CNR: an Italian prostate cancer monitoring project 140
Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy 134
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 132
Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors 131
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis 128
Reply to 'Comment on 'Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study'' 127
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 126
THE ROLE OF PRIMARY SURGERY AND EXTERNAL BEAM RADIATION THERAPY IN THE MANAGEMENT OF NON-METASTATIC DUCTAL PROSTATE CANCER: 20-YEAR OUTCOMES FROM A SINGLE INSTITUTION EXPERIENCE 124
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) 123
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 123
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 117
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease. 116
Oligometastatic prostate cancer patients stratification: A molecular signature identified by liquid biopsy 115
Role of external beam radiotherapy in the treatment of relapsing meningioma 114
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial 109
Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature 106
Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelines 105
Radiation Tolerance of Normal Brain: QUANTEC 2010 and Beyond 102
Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature. 102
Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique 102
Radiotherapy for adult medulloblastoma: Long term result from a single institution. A review of prognostic factors and why we do need a multi-institutional cooperative program 101
Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes 97
Postoperative radiotherapy for prostate cancer: the sooner the better and potential to reduce toxicity even further 97
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 97
Stereotactic body radiotherapy for lung oligometastases impacts on systemic treatment-free survival: a cohort study 95
From Molecular to Clinical Radiation Biology of Glioblastoma 94
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed? 92
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 91
Combining Abiraterone and Radiotherapy in Prostate Cancer Patients Who Progressed During Abiraterone Therapy 90
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 87
The growing role of biology in the treatment of glioblastoma: no more one kind of disease 85
Exploring the role of enzalutamide in combination with radiation therapy: An in vitro study 83
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy 82
GUROPA survey: genito-urinary radiation oncology prescription attitudes 81
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO) 81
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 81
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 80
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice 80
Cetuximab and Radiation Therapy in Head and Neck Cancer 78
Three-dimensional conformal radiotherapy, static intensity-modulated and helical intensity-modulated radiotherapy in glioblastoma. Dosimetric comparison in patients with overlap between target volumes and organs at risk. 75
Circulating Tumour Cells in Clinical Practice: Can Lessons Learned From Locally Advanced/Metastatic Breast and Prostate Cancers Guide Their use for other Cancer Types? Lights and Shadows 66
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alterations: from Their Spatial Distribution to the Use in Clinical Practice 66
Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events 65
A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patients 64
Applying radiation protection and safety in radiotherapy 62
The “Radioresistance” of Glioblastoma in the Clinical Setting, and the Present Therapeutic Options 61
The impact of tumor histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients 59
The linguistic validation process of the Vanderbilt Head and Neck Symptom Survey - Italian Version (VHNSS-IT) 59
When Less Is More: Specific Capture and Analysis of Tumor Exosomes in Plasma Increases the Sensitivity of Liquid Biopsy for Comprehensive Detection of Multiple Androgen Receptor Phenotypes in Advanced Prostate Cancer Patients 59
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) 58
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 53
A simplified integrated molecular and immunohistochemistry-based algorithm allows high accuracy prediction of glioblastoma transcriptional subtypes 51
Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary group 51
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 47
Modeling Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in the TRAMP Model of Prostate Cancer 43
Letter to the editor regarding “Lack of supporting data make the risks of a clinical trial of radiation therapy as a treatment for COVID-19 pneumonia unacceptable” 43
Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study 41
Metastasis-directed Therapy (SBRT) Guided by PET-CT 18F-CHOLINE Versus PET-CT 68Ga-PSMA in Castration-sensitive Oligorecurrent Prostate Cancer: A Comparative Analysis of Effectiveness 40
A pilot study on the Vanderbilt head and neck symptom survey Italian version (VHNSS-IT) to test its feasibility and utility in routine clinical practice 39
PROLAPSE: survey about local prostate cancer relapse salvage treatment with external beam re-irradiation: results of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 38
Stereotactic prostate radiotherapy with or without androgen deprivation therapy, study protocol for a phase III, multi-institutional randomized-controlled trial 34
Caveolin-1 promotes radioresistance in rhabdomyosarcoma through increased oxidative stress protection and DNA repair 34
Radiation therapy during the coronavirus disease 2019 (covid-19) pandemic in Italy: A view of the nation's young oncologists 33
Radiotherapy for the treatment of solitary plasmacytoma: 7-year outcomes by a mono-institutional experience 31
A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin's Lymphoma 28
Stereotactic ablative radiotherapy in castration-resistant prostate cancer patients with oligoprogression during androgen receptor-targeted therapy 24
Health-related quality of life 24-month after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study 22
Low-dose Lung Radiotherapy for COVID-19-related Pneumonia: Preliminary Results of the Italian Mono-institutional COLOR-19 Trial 21
RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic Treatment 21
Stratification of Oligometastatic Prostate Cancer Patients by Liquid Biopsy: Clinical Insights from a Pilot Study 20
Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience 20
Combining abiraterone and radiotherapy in metastatic castration-resistant prostate cancer: a review of current evidence 20
OLIGO-AIRO: a national survey on the role of radiation oncologist in the management of OLIGO-metastatic patients on the behalf of AIRO 19
PSMA-guided metastases directed therapy for bone castration sensitive oligometastatic prostate cancer: a multi-institutional study 18
Anal squamous cell carcinoma: Impact of radiochemotherapy evolution over years and an explorative analysis of MRI prediction of tumor response in a mono-institutional series of 131 patients 15
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors 15
'Le Roi est mort, vive le Roi': New Roles of Radiotherapy in the Treatment of Lymphomas in Combination With Immunotherapy 14
Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis 14
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance 13
Stereotactic radiotherapy with simultaneous integrated protection planning technique for synovial sarcoma with stomach abutment: A case report of a complete response 11
Biological Bases of Immune-Related Adverse Events and Potential Crosslinks With Immunogenic Effects of Radiation 8
Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study 8
Impact of Gastrointestinal Side Effects on Patients' Reported Quality of Life Trajectories after Radiotherapy for Prostate Cancer: Data from the Prospective, Observational Pros-IT CNR Study 7
Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in response to Onal's letter to the editor 6
Ductal prostate cancer: Clinical features and outcomes from a multicenter retrospective analysis and overview of the current literature 6
Long-term outcome of re-irradiation for recurrent or second primary head and neck cancer: A multi-institutional study of AIRO-Head and Neck working group 5
How Has Prostate Cancer Radiotherapy Changed in Italy between 2004 and 2011? An Analysis of the National Patterns-Of-Practice (POP) Database by the Uro-Oncology Study Group of the Italian Society of Radiotherapy and Clinical Oncology (AIRO) 4
Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting 4
Radiotherapy at oligoprogression for metastatic castration-resistant prostate cancer patients: a multi-institutional analysis 4
Salvage Stereotactic Reirradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: A Retrospective Multicenter Study 4
Heterogeneity in regional changes in body composition induced by androgen deprivation therapy in prostate cancer patients: potential impact on bone health-the BLADE study 3
Concomitant radiotherapy and TKI in metastatic EGFR- or ALK-mutated non-small cell lung cancer: a multicentric analysis on behalf of AIRO lung cancer study group 3
Prostate Cancer Treatment-Related Toxicity: Comparison between 3D-Conformal Radiation Therapy (3D-CRT) and Volumetric Modulated Arc Therapy (VMAT) Techniques 3
Universal testing for COVID-19 in patients undergoing cancer treatment during the second outbreak in Brescia 2
Totale 6.696
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.482
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.482
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019613 0 0 3 12 29 13 70 53 17 98 169 149
2019/20201.928 197 79 74 161 124 273 248 214 163 210 77 108
2020/20211.736 62 169 93 179 92 223 78 168 140 261 140 131
2021/2022744 65 100 26 28 12 48 31 66 39 80 38 211
2022/2023902 96 35 34 52 90 185 16 111 159 9 75 40
2023/2024266 70 31 165 0 0 0 0 0 0 0 0 0
Totale 6.701